antimicrobial susceptibility of stenotrophomonas maltophilia clinical isolates from blood samples in iran
Authors
abstract
introduction: stenotrophomonas maltophilia is a nosocomial multi drug resistant opportunistic pathogen which causes infections in vulnerable patients with cancer, cystic fibrosis and indwelling catheters. methods: 45 clinical s. maltophilia isolates were collected from blood samples and identified by biochemical tests. susceptibility to different antibiotics including co-trimoxazole, levofloxacin, minocycline, ticarcillin/clavulanic acid, chloramphenicol and ceftazidime were determined by disk diffusion and e-test methods. results: all isolates were resistant to ceftazidime and susceptible to co-trimoxazole and 11.1% were resistant to ticarcillin/clavulanic acid. conclusion: ceftazidime as one of the extended spectrum β-lactams was the least effective antibiotic. ticarcillin/clavulanic acid is one of the choosen antibiotics for s. maltophilia infections treatment. here, we report tcarcillin/clavulanic acid resistance in s. maltophilia isolates for the first time in iran.
similar resources
Antimicrobial Susceptibility of Stenotrophomonas maltophilia Clinical Isolates from Blood Samples in Iran
Introduction: Stenotrophomonas maltophilia is a nosocomial multi drug resistant opportunistic pathogen which causes infections in vulnerable patients with cancer, cystic fibrosis and indwelling catheters. Methods: 45 clinical S. maltophilia isolates were collected from blood samples and identified by biochemical tests. Susceptibility to different antibiotics including co-trimoxazole, levofloxac...
full textAntimicrobial Susceptibility of Stenotrophomonas maltophilia Clinical Isolates from Blood Samples in Iran
Stenotrophomonas maltophilia is a gram negative rod shaped bacteria which causes serious nosocomial infections in immuno-deficient populations such as HIV infected ones, patients with cancer, neutropenia and specially cystic fibrosis and stem cell transplantation recipients. This microorganism has a high mortality rate and is one of the most important agents of blood and respiratory tract infec...
full textAntimicrobial Resistance Pattern of Stenotrophomonas maltophilia Isolates from a Tertiary Care Setting in Rawalpindi, Pakistan
Introduction: Stenotrophomonas maltophilia is intrinsically resistant to many antimicrobials. Like Pseudomonas spp., this bacterium has a remarkable ability to cause infections, particularly in the respiratory and urinary tracts. This study aims to determine the antimicrobial resistance pattern of S. maltophilia isolates collected from a tertiary care setting and frequency of multi, extensively...
full textAntimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from a Korean Tertiary Care Hospital
We determined the antimicrobial susceptibility of 90 clinical isolates of Stenotrophomonas maltophilia collected in 2009 at a tertiary care hospital in Korea. Trimethoprim-sulfamethoxazole, minocycline, and levofloxacin were active against most of the isolates tested. Moxifloxacin and tigecycline were also active and hold promise as therapeutic options for S. maltophilia infections.
full textAntimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis.
Stenotrophomonas maltophilia is a newly emerging pathogen being detected with increasing frequency in patients with cystic fibrosis (CF). The impact of this multidrug-resistant organism on lung function is uncertain. The optimal treatment for S. maltophilia in CF patients is unknown. We studied the in vitro activity of ten antimicrobial agents, and conducted synergy studies by using checkerboar...
full textSmqnr VARIANTS IN CLINICAL ISOLATES OF Stenotrophomonas maltophilia IN BRAZIL
Stenotrophomonas maltophilia contains a novel chromosomally-encoded qnr gene named Smqnr that contributes to low intrinsic resistance to quinolone. We described Smqnr in 13 clinical isolates of S. maltophilia from two Brazilian hospitals, over a 2-year period. The strains were identified by API 20 NE (bioMérieux, France). Susceptibility by microdilution method to trimetroprim/sulfamethoxazole, ...
full textMy Resources
Save resource for easier access later
Journal title:
journal of medical microbiology and infectious diseasesجلد ۳، شماره ۱، صفحات ۳۵-۳۷
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023